Discontinued — last reported Q3 '23
EQT Corporation Equity Method Investments increased by 6.5% to $3.87B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.0%, from $3.55B to $3.87B.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $3.36B | $3.62B | $3.55B | $3.59B | $3.57B | $3.63B | $3.87B |
| QoQ Change | — | — | +7.7% | -1.9% | +1.2% | -0.6% | +1.8% | +6.5% |
| YoY Change | — | — | — | — | — | +6.2% | +0.4% | +9.0% |
| Segment | Q3 '24 |
|---|---|
| Transmission | $3.36B |
| Gathering | $0.00 |
| Production | $0.00 |
| Total | $3.36B |
Gathering, Production, Transmission were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|
| Transmission | $3.53B | $3.50B | $3.50B | $3.48B | $3.51B | $3.78B |
| Gathering | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Production | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Upstream | — | — | — | — | $0.00 | $0.00 |
| Total | $3.62B | $3.55B | $3.59B | $3.57B | $3.63B | $3.87B |
Production was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.